Cellular and molecular features of HIV-associated Kaposi's sarcoma

Voclosporin shows protective effect and intestinal barrier enforcement in experimental colitis.

Frontiers in medicine·2026

Reduced cytotoxicity by mutation of lysine 590 of Pseudomonas exotoxin can be restored in an optimized, lysine-free immunotoxin.

Immunotherapy advances·2022

Usability and Suitability of the Omics-Integrating Analysis Platform tranSMART for Translational Research and Education.

Applied clinical informatics·2017

Predictive value of PD-L1 based on mRNA level in the treatment of stage IV melanoma with ipilimumab.

Journal of cancer research and clinical oncology·2017

A role for MALT1 activity in Kaposi's sarcoma-associated herpes virus latency and growth of primary effusion lymphoma.

Leukemia·2016

Molecular staging of lymph node-negative colon carcinomas by one-step nucleic acid amplification (OSNA) results in upstaging of a quarter of patients in a prospective, European, multicentre study.

British journal of cancer·2014

LDL-C target achievement in people living with HIV: impact of combination lipid-lowering therapy. A retrospective cohort analysis.

AIDS (London, England)·2026

Longitudinal trends in copy-years viremia associated with mpox acquisition but not mpox severity in people with HIV.

AIDS (London, England)·2026

Sex differences in long-acting cabotegravir trough concentrations in the SEARCH study in Kenya and Uganda.

AIDS (London, England)·2026

Changes in neurodevelopmental outcomes from 24 to 36 months among children HIV-exposed uninfected (CHEU) and HIV-unexposed (CHU).

AIDS (London, England)·2026

Reframing analytical treatment interruption through participants' and decliners' eyes: insights from an HIV remission trial.

AIDS (London, England)·2026

Ninety-six-week observational outcomes of long-acting injectable HIV therapy in people with adherence challenges, including people who use drugs.

AIDS (London, England)·2026

Anakinra Prophylaxis for Recurrent Severe ICANS Associated With Tarlatamab in Small Cell Lung Cancer: Case Report.

JTO clinical and research reports·2026

Prognostic value of CD103+ tumor-infiltrating lymphocytes in bladder cancer: A systematic review and meta-analysis.

Urologic oncology·2026

Immunotherapy for Glioma: A compartmental framework for resistance and rational combination design.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026

B-cells in breast cancer: current insights and challenges.

Frontiers in oncology·2026

Tumor immunosenescence drives breast cancer progression and therapeutic resistance: mechanisms and emerging interventions.

Frontiers in oncology·2026

The heterogeneous and dynamic immune-tumor interface in breast cancer.

Frontiers in oncology·2026

Related Experiment Videos

Cellular and molecular features of HIV-associated Kaposi's sarcoma

Related Concept Videos

Voclosporin shows protective effect and intestinal barrier enforcement in experimental colitis.

Reduced cytotoxicity by mutation of lysine 590 of Pseudomonas exotoxin can be restored in an optimized, lysine-free immunotoxin.

Usability and Suitability of the Omics-Integrating Analysis Platform tranSMART for Translational Research and Education.

Predictive value of PD-L1 based on mRNA level in the treatment of stage IV melanoma with ipilimumab.

A role for MALT1 activity in Kaposi's sarcoma-associated herpes virus latency and growth of primary effusion lymphoma.

Molecular staging of lymph node-negative colon carcinomas by one-step nucleic acid amplification (OSNA) results in upstaging of a quarter of patients in a prospective, European, multicentre study.

LDL-C target achievement in people living with HIV: impact of combination lipid-lowering therapy. A retrospective cohort analysis.

Longitudinal trends in copy-years viremia associated with mpox acquisition but not mpox severity in people with HIV.

Sex differences in long-acting cabotegravir trough concentrations in the SEARCH study in Kenya and Uganda.

Changes in neurodevelopmental outcomes from 24 to 36 months among children HIV-exposed uninfected (CHEU) and HIV-unexposed (CHU).

Reframing analytical treatment interruption through participants' and decliners' eyes: insights from an HIV remission trial.

Ninety-six-week observational outcomes of long-acting injectable HIV therapy in people with adherence challenges, including people who use drugs.

Anakinra Prophylaxis for Recurrent Severe ICANS Associated With Tarlatamab in Small Cell Lung Cancer: Case Report.

Prognostic value of CD103+ tumor-infiltrating lymphocytes in bladder cancer: A systematic review and meta-analysis.

Immunotherapy for Glioma: A compartmental framework for resistance and rational combination design.

B-cells in breast cancer: current insights and challenges.

Tumor immunosenescence drives breast cancer progression and therapeutic resistance: mechanisms and emerging interventions.

The heterogeneous and dynamic immune-tumor interface in breast cancer.

Related Experiment Videos

Cellular and molecular features of HIV-associated Kaposi's sarcoma

Related Concept Videos

Related Articles